Medtronic, Inc. (Medtronic) is a medical technology company engaged in the development, manufacture and marketing of a wide range of medical devices, therapies and services used to treat chronic conditions such as heart disease, spinal conditions, neurological disorders, vascular disease and diabetes. The company principally operates in the US, Europe and Asia-Pacific. It serves physicians, patients and clinicians in over 120 countries around the world. The company is headquartered in Minnesota, the US.
The company generates revenues through seven business segments: Cardiac Rhythm Disease Management (CRDM) segment accounted for 34.3% of the total revenues during the fiscal year 2009, Spinal segment (23.3%), CardioVascular segment (16.7%), Neuromodulation segment (9.8%), Diabetes segment (7.6%), Surgical Technologies segment (5.9%) and Physio-Control segment (2.4%).
Medtronic generates revenues through four geographical segments, namely: the US accounted for 61.6% of the total revenues during the fiscal year 2009, Europe (24.4%), Asia Pacific (10.7%) and Other Foreign (3.3%).The company reported revenues of (U.S. Dollars) USD 14,599.00 million during the fiscal year ended April 2009, an increase of 8.02% over 2008. The operating profit of the company was USD 2,594.00 million during the fiscal year 2009, a decrease of 10.09% from 2008. The net profit of the company was USD 2,169.00 million during the fiscal year 2009, a decrease of 2.78% from 2008.